Pathobiology 1994-01-01

Complement C3 deficiency: human, animal, and experimental models.

L Singer, H R Colten, R A Wetsel

Index: Pathobiology 62 , 14-28, (1994)

Full Text: HTML

Abstract

The third complement component (C3) is a multifunctional glycoprotein that interacts with numerous serum proteins, cell surface receptors, and membrane-associated regulatory proteins. Deficiencies of C3 have been reported in several human kindred of different ethnic backgrounds and from different geographic regions. In addition, inherited C3 deficiency has been discovered in certain strains of guinea pigs, dogs, and rabbits, and has been experimentally induced in animals by injections of cobra venom factor. Studies of the C3-deficient humans and animals have demonstrated the important roles performed by C3 in the immune response, opsonization and phagocytosis of pathogens, and immune complex solubilization. Current knowledge of the molecular and cellular basis of complement C3 deficiency indicates that C3 deficiency is caused by numerous molecular genetic mutations that include splicing defects, a partial gene deletion, and a critical amino acid substitution. With the advent of gene ablation technology, C3-deficient murine models can now be established, making it possible to examine the role that C3 plays in the molecular pathogenesis of many different diseases.


Related Compounds

Related Articles:

Immune evasion of Enterococcus faecalis by an extracellular gelatinase that cleaves C3 and iC3b.

2008-11-01

[J. Histochem. Cytochem. 181 , 6328-36, (2008)]

Group A streptococcal cysteine protease degrades C3 (C3b) and contributes to evasion of innate immunity.

2008-03-07

[J. Biol. Chem. 283 , 6253-6260, (2008)]

The role of complement and complement receptors in induction and regulation of immunity.

1998-01-01

[Annu. Rev. Immunol. 16 , 545-568, (1998)]

Tyrosines of human and mouse transferrin covalently labeled by organophosphorus agents: a new motif for binding to proteins that have no active site serine.

2009-01-01

[Toxicol. Pathol. 107 , 144-55, (2009)]

Degradation of complement 3 by streptococcal pyrogenic exotoxin B inhibits complement activation and neutrophil opsonophagocytosis.

2008-03-01

[Infect. Immun. 76 , 1163-1169, (2008)]

More Articles...